Skip to content

An exploratory study on the effect of a gummy candy intake on salivary secretion.

An exploratory study on the effect of a gummy candy intake on salivary secretion. - An exploratory study on the effect of a gummy candy intake on salivary secretion.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000045256
Enrollment
22
Registered
2021-08-25
Start date
2021-09-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Take one gummy candy at once. Take one chewing gum at once.

Sponsors

IMEQRD Co., Ltd
Lead Sponsor
CPCC Company Limited Chiyoda Oralhealth Care Clinic Meiji Co., Ltd
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Those who were given sufficient explanations of the trial information, and signed the document of the informed consent with well understanding of the trial objective; also, those who voluntarily joined the trial. 2. Healthy females aged between 50 to 65. 3. Postmenopausal females. 4. Those who have the volume of saliva secreted between 2-6 g are assessed by the Saxon test.

Exclusion criteria

Exclusion criteria: 1. Those who cannot intake gummy candies or chewing gums, because of any reasons (e.g. preference for the foods, or under dental treatment, etc). 2. Those who have food allergies. 3. Those who have a smoking habit, or those who had a smoking habit within 1 year before this study. 4. Those who have any severe or progressive diseases. 5. Those who were diagnosed with dry mouth by medical doctors. 6. Those who have been taking foods and supplements to obtain health benefits over 5 times every week and/or over 1 month. 7. Those who take calcium channel blockers, hypnotics, anti-anxiety agents, or anti-depressive agents. 8. Those who joined other clinical trials or monitoring surveys (limited to the trials which are accompanied with oral intake or oral administration) within 1 month before obtaining informed consent on this study. 9. Those who are planning extremely change their lifestyle (such as diet, sleep, or exercise) during the trial period. 10. Those who are unsuitable for this study that judged by the principal investigator.

Design outcomes

Primary

MeasureTime frame
The volume of saliva secreted The rate of salivary secretion

Secondary

MeasureTime frame
Salivary IgA (s-IgA) Subjective questionnaire

Countries

Japan

Contacts

Public ContactHirokuni Kayama

IMEQRD Co., Ltd Planning and Sales Department

clinical-trial@imeqrd.co.jp03-6704-5968

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026